Back to search

Article

The reciprocal loop of MALAT1 and HIF-1α facilitates gemcitabine resistance in pancreatic cancer by enhancing glycolysis

2021-04-12

Abstract excerpt

<title>Abstract</title> <p><bold>Background:</bold> Profound chemoresistance is a prominent and intractable problem in pancreatic cancer. Gemcitabine, a first-line chemotherapeutic drug for pancreatic cancer, has provided only minimal benefits for patients; however, the underlying mechanisms remain to be investigated. Enhanced aerobic glycolysis has been suggested to be correlated with the phenotype of drug resis...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work
c6e9b908-690c-57f4-94db-15265171a732
DOI
10.21203/rs.3.rs-135235/v2
Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest
Interactive article relationship graphSelect a related publication card to move it into the centre and load its closest explainable connections. Solid lines are source-backed structured connections. Dashed lines are semantic discovery signals and are not scientific evidence.
The reciprocal loop of MALAT1 and HIF-1α facilitates gemcitabine resistance in pancreatic cancer by enhancing glycolysisDOI 10.21203/rs.3.rs-135235/v2
Select a neighboring publication to make it the new centre.